FINWIRES · TerminalLIVE
FINWIRES

Leerink Partners Downgrades Gilead Sciences to Market Perform From Outperform, Adjusts PT to $127 From $146

By

Gilead Sciences (GILD) has an average rating of overweight and mean price target of $159.74, according to analysts polled by FactSet.

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

Related Articles

Research

Morgan Stanley Downgrades NNN REIT to Equal Weight From Overweight, $50 Price Target

NNN REIT (NNN) has an average rating of hold and mean price target of $45.63 according to analysts polled by FactSet.Price: $48.84, Change: $-0.75, Percent Change: -1.51%

$NNN
Research

Needham Downgrades Personalis to Hold From Buy

Personalis (PSNL) has an average rating of Buy and mean price target of $12.40, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $13.21, Change: $-2.18, Percent Change: -14.17%

$PSNL
Research

DNB Carnegie Upgrades Saab to Buy, Boosts PT

DNB Carnegie on Monday upgraded Swedish defense and security group Saab (SAAB-B.ST) to buy from hold and raised the price target to 630.00 kronor from 550.00 kronor.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

$SAAB-B.ST